KNSA |
Kiniksa Pharmaceuticals, Ltd. |
Jun 5, 2024 |
4 |
$0 |
4 |
Jun 7, 2024 |
Director |
BPMC |
Blueprint Medicines Corp |
Mar 7, 2024 |
1 |
-$471K |
4 |
Mar 11, 2024 |
EVP AND CHIEF LEGAL OFFICER |
BPMC |
Blueprint Medicines Corp |
Mar 1, 2024 |
2 |
$0 |
4 |
Mar 6, 2024 |
EVP AND CHIEF LEGAL OFFICER |
IMGN |
ImmunoGen, Inc. |
Feb 12, 2024 |
5 |
$0 |
4 |
Feb 12, 2024 |
Director |
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
Jun 29, 2023 |
2 |
$0 |
4 |
Jul 3, 2023 |
Director |
IMGN |
ImmunoGen, Inc. |
Jun 14, 2023 |
2 |
$0 |
4 |
Jun 16, 2023 |
Director |
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
Jun 6, 2023 |
2 |
$0 |
4 |
Jun 8, 2023 |
Director |
BPMC |
Blueprint Medicines Corp |
Mar 6, 2023 |
2 |
-$152K |
4 |
Mar 8, 2023 |
EVP AND CHIEF LEGAL OFFICER |
BPMC |
Blueprint Medicines Corp |
Mar 1, 2023 |
2 |
$0 |
4 |
Mar 3, 2023 |
EVP AND CHIEF LEGAL OFFICER |
IMGN |
ImmunoGen, Inc. |
Dec 30, 2022 |
1 |
$0 |
4 |
Jan 4, 2023 |
Director |
IMGN |
ImmunoGen, Inc. |
Sep 30, 2022 |
1 |
$0 |
4 |
Oct 4, 2022 |
Director |
IMGN |
ImmunoGen, Inc. |
Jun 30, 2022 |
1 |
$0 |
4 |
Jul 5, 2022 |
Director |
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
Jun 29, 2022 |
2 |
$0 |
4 |
Jun 30, 2022 |
Director |
IMGN |
ImmunoGen, Inc. |
Jun 15, 2022 |
2 |
$86.1K |
4 |
Jun 17, 2022 |
Director |
IMGN |
ImmunoGen, Inc. |
Mar 31, 2022 |
1 |
$0 |
4 |
Apr 4, 2022 |
Director |
BPMC |
Blueprint Medicines Corp |
Mar 3, 2022 |
2 |
-$159K |
4 |
Mar 8, 2022 |
EVP AND CHIEF LEGAL OFFICER |
BPMC |
Blueprint Medicines Corp |
Mar 1, 2022 |
2 |
$0 |
4 |
Mar 3, 2022 |
EVP AND CHIEF LEGAL OFFICER |
BPMC |
Blueprint Medicines Corp |
Dec 7, 2021 |
5 |
-$345K |
4 |
Dec 9, 2021 |
EVP and Chief Legal Officer |
IMGN |
ImmunoGen, Inc. |
Nov 15, 2021 |
2 |
$250K |
4 |
Nov 17, 2021 |
Director |
IMGN |
ImmunoGen, Inc. |
Nov 15, 2021 |
0 |
$0 |
3 |
Nov 17, 2021 |
Director |
BPMC |
Blueprint Medicines Corp |
Nov 3, 2021 |
4 |
-$411K |
4 |
Nov 5, 2021 |
EVP and Chief Legal Officer |
BPMC |
Blueprint Medicines Corp |
Sep 23, 2021 |
5 |
-$2.01M |
4 |
Sep 27, 2021 |
EVP and Chief Legal Officer |
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
Jun 29, 2021 |
1 |
$0 |
4 |
Jun 30, 2021 |
Director |